Review: Aromatase inhibitors for ovulation induction

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 3, 2006, Pages 760-771

  Casper, Robert F ^a,c   Mitwally, Mohamed F M ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANASTROZOLE; AROMATASE INHIBITOR; CLOMIFENE CITRATE; ENCLOMIFENE; EXEMESTANE; FADROZOLE; FOLLITROPIN; FORMESTANE; GONADOTROPIN; LETROZOLE; ZN 1033; ZUCLOMIFENE;

ANOVULATION; BREAST CANCER; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG TREATMENT FAILURE; ENZYME INHIBITION; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GASTROINTESTINAL SYMPTOM; HOT FLUSH; HUMAN; MULTIPLE PREGNANCY; OVULATION; OVULATION INDUCTION; PREGNANCY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UTERINE CERVIX MUCUS;

ANOVULATION; AROMATASE INHIBITORS; CLOMIPHENE; FEMALE; HUMANS; OVULATION; OVULATION INDUCTION;

EID: 33644844652     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1923     Document Type: Review

References (106)

1. Gougeon A 1998 Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas 30:137-142
2. Gougeon A 1986 Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1:81-87
3. Le Nestour E, Marraoui J, Lahlou N, Roger M, de Ziegler D, Bouchard P 1993 Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. J Clin Endocrinol Metab 77:439-442
4. Marsters P, Kendall NR, Campbell BK 2003 Temporal relationships between FSH receptor, type 1 insulin-like growth factor receptor, and aromatase expression during FSH-induced differentiation of bovine granulosa cells maintained in serum-free culture. Mol Cell Endocrinol 203:117-127
5. Armstrong DT, Dorrington JH 1977 Estrogen biosynthesis in the ovaries and testes. Adv Sex Horm Res 3:217-258
6. Brown JB 1978 Pituitary control of ovarian function - concepts derived from gonadotrophin therapy. Aust N Z J Obstet Gynaecol 18:46-54
7. Fauser BCJM, van Heusden AM 1997 Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 18:71-106
8. Macklon NS, Fauser BC 2000 Impact of ovarian hyperstimulation on the luteal phase. J Reprod Fertil Suppl 55:101-108
9. Shima K, Kitayama S, Nakano R 1987 Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstet Gynecol 69:800-806
10. Zeleznik AJ, Hillier SG 1984 The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynecol 27:927-940
11. Sullivan MW, StewarAkers A, Krasnow JS, Berga SL, Zeleznik AJ 1999 Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation. J Clin Endocrinol Metab 84:228-232
12. Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B 2005 Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 84:394-401
13. Liu JH, Yen SS 1983 Induction of midcycle gonadotropin surge by ovarian steroids in women: a critical evaluation. J Clin Endocrinol Metab 57:797-802
14. Christian CA, Mobley JL, Moenter SM 2005 Diurnal and estradiol-dependent changes in gonadotropin-releasing hormone neuron firing activity. Proc Natl Acad Sci USA 102:15682-15687
15. Baerwald AR, Pierson RA 2004 Endometrial development in association with ovarian follicular waves during the menstrual cycle. Ultrasound Obstet Gynecol 24:453-460
16. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW 2000 Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 80:1-29
17. Finkelstein JS, Badger TM, O'Dea LS, Spratt DI, Crowley WF 1988 Effects of decreasing the frequency of gonadotropin-releasing hormone stimulation on gonadotropin secretion in gonadotropin-releasing hormone-deficient men and perifused rat pituitary cells. J Clin Invest 81:1725-1733
18. Ropert JF, Quigley ME, Yen SS 1981 Endogenous opiates modulate pulsatile luteinizing hormone release in humans. J Clin Endocrinol Metab 52:583-585
19. Greenblatt RB, Barfield WE, Jungck EC, Ray AW 1961 Induction of ovulation with MRL/41. JAMA 178:101-105
20. Mikkelson TJ, Kroboth PD, Cameron WJ 1986 Single dose pharmacokinetics of clomiphene citrate in normal volunteers. Fertil Steril 46:392
21. Young SL, Opsahl MS, Fritz MA 1999 Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. Fertil Steril 7:639-644
22. Kurl RN, Morris ID 1978 Differential depletion of cytoplasmic high affinity oestrogen receptors after the in vivo administration of the antioestrogens, clomiphene, MER-25 and tamoxifen. Br J Pharmacol 62:487-493
23. Kerin JF, Liu JH, Phillipou G, Yen SSS 1985 Evidence for a hypothalamic site of action of clomiphene citrate in women. J Clin Endocrinol Metab 61:265-268
24. Kettel LM, Roseff SJ, Berga SL, Mortola JF, Yen SS 1993 Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome. Fertil Steril 59:532-538
25. Fisher SA, Reid RL, Van Vugt DA, Casper RF 2002 A randomized double-blind comparison of the effects of clomiphene citrate and the AI letrozole on ovulatory function in normal women. Fertil Steril 78:280-285
26. Fisch B, Margara RA, Winston RM, Hillier SG 1989 Cellular basis of luteal steroidogenesis in the human ovary. J Endocrinol 122:303-311
27. Garcia J, Seegar Jones G, Wentz AC 1977 The use of clomiphene citrate. Fertil Steril 28:707-717
28. Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC 1999 Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligomenorrheic infertility. J Clin Endocrinol Metab 84:1617-1622
29. Capelo FO, Kumar A, Steinkampf MP, Azziz R 2003 Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate. Fertil Steril 80:1450-1453
30. Hakim RB, Gray RH, Zacur H 1995 Infertility and early pregnancy loss. Am J Obstet Gynecol 1725:1510-1517
31. Check JH, Dietterich C, Lurie D 1995 The effect of consecutive cycles of clomiphene citrate therapy on endometrial thickness and echo pattern. Obstet Gynecol 86:341-345
32. Gonen Y, Casper RF 1990 Sonographic determination of an adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 5:670-674
33. Ben-Ami M, Geslevich Y, Matilsky M, Battino S, Weiner E, Shalev E 1994 Exogenous estrogen therapy concurrent with clomiphene citrate: lack of effect on serum sex hormones and endometrial thickness. Gynecol Obstet Invest 37:180-182
34. Nelson LM, Hershlag A, Kurl RS, Hall JL, Stillman RJ 1990 Clomiphene citrate directly impairs endometrial receptivity in the mouse. Fertil Steril 53:727-731
35. Li TC, Warren MA, Murphy C, Sargeant S, Cooke ID 1992 A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal fertile women. Br J Obstet Gynaecol 99:1008-1013
36. Fritz MA, Holmes RT, Keenan EJ 1991 Effect of clomiphene citrate treatment on endometrial estrogen and progesterone receptor induction in women. Am J Obstet Gynecol 165:177-185
37. Yeko TR, Nicosia SM, Maroulis GB, Bardawil WA, Dawood MY 1992 Histology of midluteal corpus luteum and endometrium from clomiphene citrate-induced cycles. Fertil Steril 57:28-32
38. Sereepapong W, Triratanachat S, Sampatanukul P, Pruksananonda K, Boonkasemsanti K, Reinprayoon D 2000 Effects of clomiphene citrate on the endometrium of regularly cycling women. Fertil Steril 73:287-291
39. Hsu CC, Kuo HC, Wang ST, Huang KE 1995 Interference with uterine blood flow by clomiphene citrate in women with unexplained infertility. Obstet Gynecol 866:917-921
40. Cole PA, Robinson CH 1990 Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem 33:2933-2944
41. Santen RJ, Manni A, Harvey H, Redmond C 1990 Endocrine treatment of breast cancer in women. Endocr Rev 11:1-45
42. Buzdar A, Howell A 2001 Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. Clin Cancer Res 7:2620-2635
43. Santen RJ, Lipton A, Kendall J 1974 Successful medical adrenalectomy with aminoglutethimide: role of altered drug metabolism. JAMA 230:1661-1665
44. Newsome Jr HH, Brown PW, Terz JJ, Lawrence Jr W 1977 Medical and surgical adrenalectomy in patients with advanced breast carcinoma. Cancer 39:542-546
45. Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP 2002 American Society of Clinical Oncology technology assessment on the use of AIs as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol 2015:3317-3327
46. Buzdar A, Jonat W, Howell A, Jones SE, Blomqvist C, Vogel CL, Eiermann W, Wolter JM, Azab M, Webster A, Plourde PV 1996 Anastrozole, a potent and selective AI, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. J Clin Oncol 14:2000-2011
47. Dowsett M 1996 Biological background to aromatase inhibition. Breast 5:196-201
48. Mauras N, Lima J, Patel D, Rini A, di Salle E, Kwok A, Lippe B 2003 Pharmacokinetics and dose finding of a potent AI, aromasin (exemestane), in young males. J Clin Endocrinol Metab 88:5951-5956
49. Kamat A, Hinshelwood MM, Murry BA, Mendelson CR 2002 Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab 133:122-128
50. Naftolin F, MacLusky NJ 1984 Aromatization hypothesis revisited. In: Serio M, ed. Differentiation: basic and clinical aspects. New York: Raven Press; 79-91
51. Naftolin F, MacLusky NJ, Leranth CZ, Sakamoto HS, Garcia-Segura LM 1988 The cellular effects of estrogens on neuroendocrine tissues. J Steroid Biochem 30:195-207
52. Naftolin F 1994 Brain aromatization of androgens. J Reprod Med 39:257-261
53. Roberts V, Meunier H, Vaughan J, Rivier J, Rivier C, Vale W, Sawchenko P 1989 Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology 124:552-554
54. Mason AJ, Berkemeier LM, Schmelzer CH, Schwall RH 1989 Activin B: precursor sequences, genomic structure and in vitro activities. Mol Endocrinol 3:1352-1358
55. Sioufi A, Gauducheau N, Pineau V, Marfil F, Jaouen A, Cardot JM, Godbillon J, Czendlik C, Howald H, Pfister C, Vreeland F 1997 Absolute bioavailability of letrozole in healthy post-menopausal women. Biopharm Drug Dispos 18:779-789
56. Sioufi A, Sandrenan N, Godbillon J, Trunet P, Czendlik C, Howald H, Pfister C, Ezzet F 1997 Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 25 mg single oral administration. Biopharm Drug Dispos 186:489-497
57. Roberts VJ, Barth S, El-Roeiy A, Yen SSC 1994 Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. J Clin Endocrinol Metab 79:1434-1439
58. Yamoto M, Minami S, Nakano R 1993 Immunohistochemical localization of inhibin subunits in polycystic ovary. J Clin Endocrinol Metab 77:859-862
59. Anderson RA, Groome NP, Baird DT 1998 Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation. Clin Endocrinol (Oxf) 48:577-584
60. Lockwood GM, Muttukrishna S, Groome NP, Matthews DR, Ledger WL 1998 Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab 83:1730-1735
61. Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, Bondy CA 1998 Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab 837:2479-2485
62. Weil S, Vendola K, Zhou J, Bondy CA 1999 Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 848:2951-2956
63. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA 1998 Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 10112:2622-2629
64. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M, Bondy CA 1999 Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 612:353-357
65. Adashi E 1993 Intraovarian regulation the proposed role of insulin-like growth factors. Ann NY Acad Sci 687:10-12
66. Giudice LC 1992 Insulin-like growth factors and ovarian follicular development. Endocr Rev 13:641-669
67. Yen SSC, Laughlin GA, Morales AJ 1993 Interface between extra-and intraovarian factors in polycystic ovary syndrome PCOS. Ann NY Acad Science 687:98-111
68. Agarwal SK, Judd HL, Magoffin DA 1996 A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J Clin Endocrinol Metab 81:3686-3691
69. Jakimiuk AJ, Weitsman SR, Brzechffa PR, Magoffin DA 1998 Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod 41:1-8
70. Nirmala PB, Thampan RV 1995 Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. Biochem Biophys Res Commun 213:24-31
71. Rosenfeld CR, Roy T, Cox BE 2002 Mechanisms modulating estrogen-induced uterine vasodilation. Vascul Pharmacol 382:115-125
72. Mitwally MFM, Casper RF 2000 Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod Technol 10:244-247
73. Mitwally MFM, Casper RF 2000 Use of an AI for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75:305-309
74. Sammour A, Biljan MM, Tan SL, Tulandi T 2001 Prospective randomized trial comparing the effects of letrozole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination (IUI). Fertil Steril 76:S110
75. Cortinez A, De Carvalho I, Vantman D, Gabler F, Iniguez G, Vega M 2005 Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil Steril 83:110-115
76. Al-Fozan H, Al-Khadouri M, Tan SL, Tulandi T 2004 A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 82:1561-1563
77. Fatemi HM, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem AC, Devroey P 2003 Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reprod Biomed Online 75:543-546
78. Al-Omari WR, Sulaiman WR, Al-Hadithi N 2004 Comparison of two AIs in women with clomiphene-resistant polycystic ovary syndrome. Int J Gynaecol Obstet 853:289-291
79. Tredway DR, Buraglio M, Hemsey G, Denton G 2004 A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers. Fertil Steril 82:1587-1593
80. Ligibel JA, Winer EP 2003 Clinical differences among the AIs. Clin Cancer Res 91:473S-479S
81. de Ziegler D, Mattenberger C, Luyet C, Romoscanu I, Irion NF, Bianchi-Demicheli F 2005 Clinical use of AIs (AI) in premenopausal women. J Steroid Biochem Mol Biol 95:121-127
82. Mitwally MFM, Casper RF 2002 Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 774:776-780
83. Mitwally MF, Casper RF 2003 Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 188:1588-1597
84. Mitwally MF, Casper RF 2004 Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J Soc Gynecol Investig 11:406-415
85. Biljan MM, Tan SL, Tulandi T 2002 Prospective randomized trial comparing the effects of 2.5 and 5.0 mg of letrozole (LE) on follicular development, endometrial thickness and pregnancy rate in patients undergoing superovulation. Fertil Steril 78:S55
86. Healey S, Tan SL, Tulandi T, Biljan MM 2003 Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 806:1325-1329
87. Hamilton A, Piccart M 1999 The third-generation nonsteroidal AIs: a review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer. Ann Oncol 10:377-384
88. Goss PE 1999 Risks versus benefits in the clinical application of AIs. Endocr Relat Cancer 6:325-332
89. Palter SF, Tavares AB, Hourvitz A, Veldhuis JD, Adashi EY 2001 Are estrogens of import to primate/human ovarian folliculogenesis? Endocr Rev 223:389-424
90. Yanase T, Simpson ER, Waterman M 1991 17-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12:91-108
91. Rabinovici J, Blankstein J, Goldman B, Rudak E, Dor Y, Pariente C, Geier A, Lunenfeld B, Mashiach S 1989 In vitro fertilization and primary embryonic cleavage are possible in 17α-hydroxylase deficiency despite extremely low intrafollicular 17β-estradiol. J Clin Endocrinol Metab 68:693-697
92. Schoot DC, Coelingh Bennink HJ, Mannaerts BM, Lamberts SW, Bouchard P, Fauser BC 1992 Human recombinant FSH induced growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated GT deficiency. J Clin Endocrinol Metab 74:1471-1473
93. Shoham Z, Mannaerts B, Insler V, Coelingh HB 1993 Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil Steril 59:738-742
94. Mitwally MF, Biljan MM, Casper RF 2005 Pregnancy outcome after the use of an AI for induction of ovulation. Am J Obstet Gynecol 192:381-386
95. Tiboni GM 2004 AIs and teratogenesis. Fertil Steril 81:1158-1159
96. Biljan MM, Hemmings R, Brassard N 2005 The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 84 (Suppl 1):S95
97. Simón C, Cano F, Valbueña D,Remohí J, Pellicer A 1995 Clinical evidence for a detrimental effect on uterine receptivity of high serum E2 concentrations in high and normal responder patients. Hum Reprod 10:2432-2437
98. Paulson RJ, Sauer MV, Lobo RA 1990 Embryo implantation after human in vitro fertilization: importance of endometrial receptivity. Fertil Steril 53:870-874
99. Forman R, Fries N, Testart J, Belaisch-Allart J, Hazout A, Frydman R 1988 Evidence for an adverse effect of elevated serum estradiol concentration on embryo implantation. Fertil Steril 49:118-122
100. Valbuena D, Martin J, de Pablo JL, Remohi J, Pellicer A, Simon C 2001 Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril 765:962-968
101. Basir GS, O WS, Ng EH, Ho PC 2001 Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation. Hum Reprod 16:435-440
102. Simon C, Garcia Velasco JJ, Valbuena D, Peinado JA, Moreno C, Remohi J, Pellicer A 1998 Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril 70:234-239
103. Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN 2004 A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum Reprod 19:2031-2035
104. Garcia-Velasco JA, Moreno L, Pacheco A, Guillen A, Duque L, Requena A, Pellicer A 2005 The AI letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 84:82-87
105. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z 2005 Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347-4353
106. Casper RF 2003 Letrozole: ovulation or superovulation? Fertil Steril 80:1335-1337